CAS 14913-33-8|trans-Dichlorodiamineplatinum(II)
| Common Name | trans-Dichlorodiamineplatinum(II) | ||
|---|---|---|---|
| CAS Number | 14913-33-8 | Molecular Weight | 300.051 |
| Density | 3.746 g/cm3 | Boiling Point | / |
| Molecular Formula | H6Cl2N2Pt | Melting Point | 340ºC (dec.) |
| MSDS | ChineseUSA | Flash Point | / |
| Symbol | GHS05, GHS08 | Signal Word | Danger |
Names
| Name | transplatin |
|---|---|
| Synonym | More Synonyms |
Chemical & Physical Properties
| Density | 3.746 g/cm3 |
|---|---|
| Melting Point | 340ºC (dec.) |
| Molecular Formula | H6Cl2N2Pt |
| Molecular Weight | 300.051 |
| Exact Mass | 298.955597 |
| PSA | 6.48000 |
| LogP | 2.02430 |
| Index of Refraction | 1.706 |
| Water Solubility | Soluble in dimethylsulfoxide and dimethylformamide. Slightly soluble in water. |
Toxicological Information
CHEMICAL IDENTIFICATION |
ACUTE TOXICITY DATA - TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 27 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 32408 ug/kg/10W-I
- TOXIC EFFECTS :
- Tumorigenic - equivocal tumorigenic agent by RTECS criteria Lungs, Thorax, or Respiration - tumors
MUTATION DATA - TYPE OF TEST :
- DNA adduct
- TEST SYSTEM :
- Mammal - species unspecified Lymphocyte
- DOSE/DURATION :
- 50 umol/L
- REFERENCE :
- CBINA8 Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- Volume(issue)/page/year: 10,27,1975
- TYPE OF TEST :
- DNA adduct
- TEST SYSTEM :
- Mammal - species unspecified Lymphocyte
- DOSE/DURATION :
- 50 umol/L
- REFERENCE :
- CBINA8 Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- Volume(issue)/page/year: 10,27,1975
Safety Information
| Symbol | GHS05, GHS08 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H317-H318-H334 |
| Precautionary Statements | P261-P280-P284-P304 + P340-P305 + P351 + P338 + P310 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Faceshields;Gloves |
| Hazard Codes | T:Toxic; |
| Risk Phrases | R23/24/25;R40;R42/43;R68 |
| Safety Phrases | S24-S36/37 |
| RIDADR | UN 3288 |
| WGK Germany | 3 |
| RTECS | TP2455000 |
| Packaging Group | II |
| Hazard Class | 6.1(a) |
Articles388
More Articles| TAp73 promotes cell survival upon genotoxic stress by inhibiting p53 activity. Oncotarget 5(18) , 8107-22, (2014) p53 plays a key role in regulating DNA damage response by suppressing cell cycle progression or inducing apoptosis depending on extent of DNA damage. However, it is not clear why mild genotoxic stress... | |
| Combination of systemic chemotherapy with local stem cell delivered S-TRAIL in resected brain tumors. Stem Cells 33(1) , 101-10, (2014) Despite advances in standard therapies, the survival of glioblastoma multiforme (GBM) patients has not improved. Limitations to successful translation of new therapies include poor delivery of systemi... | |
| Crystals of Na(+)/K(+)-ATPase with bound cisplatin. Biochem. Pharmacol. 92(3) , 494-8, (2014) Cisplatin is the most widely used chemotherapeutics for cancer treatment, however, its administration is connected to inevitable adverse effects. Previous studies suggested that cisplatin is able to i... |
Synonyms
| trans--diamminedichloroplatinum(II) |
| EINECS 238-980-9 |
| trans-diamminodichloroplatinum(II) |
| trans-diaminedichloroplatinum(II) |
| UNII:Q20Q21Q62J |
| Dichloroplatinum diammoniate |
| trans-Platinum diammine dichloride |
| MFCD00011623 |
| CIS-PLATIN |
| transplatin |
| trans-dichlorodiammineplatinum(II) |
| trans-dichlorodiamine platinum(II) |
| trans-Dichlorodiamineplatinum(II) |
| Cisplatin impurity A |
| trans-Diamminedichloroplatinum(II) (trans-Dichlorodiammineplatinum(II) |
| cis-Diamminedichlorplatine |
